Septian Hartono1,2, Isabel Hui Min Chew3, Weiling Lee3, Amanda May Yeng Choo1, Celeste Yan Teng Chen1, Leon Qi Rong Ooi4, Lirong Yin3, Kuan Jin Lee5, Jongho Lee6, Ching-Yu Cheng7, Eng King Tan1,2, and Ling Ling Chan2,3
1National Neuroscience Institute, Singapore, Singapore, 2Duke-NUS Medical School, Singapore, Singapore, 3Singapore General Hospital, Singapore, Singapore, 4National University of Singapore, Singapore, Singapore, 5Singapore BioImaging Consortium, Singapore, Singapore, 6Seoul National University, Seoul, Republic of Korea, 7Singapore Eye Research Institute, Singapore, Singapore
Synopsis
Nigrosome-1 imaging and neuromelanin contrast have been
identified as good radiological biomarkers of dopaminergic nigral degeneration
in Parkinson's disease (PD) pathology. We evaluated the sensitivity of
quantitative Susceptibility-Mapping Weighted Imaging (SMWI) derived from
Quantitative Susceptibility Mapping (QSM) and neuromelanin sensitive (NMS)
imaging in differentiating a case control cohort of PD patients. Region-of-interest
analysis of the substantia nigra on both QSM/SMWI and NMS offered excellent
differentiation of PD and healthy controls. However, QSM/SMWI offered more robust
disease classification compared to NMS and might be preferred for use in the clinical
setting.
Introduction
Patients
with Parkinson’s disease (PD) are known to have dopaminergic denervation in the
substantia nigra (SN). Prior studies have shown that nigrosome-1, a subregion
of SN, and neuromelanin contrast are useful imaging surrogates to detect PD
pathology.1,2 The nigrosome-1 is radiologically delineated as a
region of signal hyperintensity on T2* susceptibility-weighted imaging (SWI) in
healthy subjects, but lost in PD.3 Dark pigmentation of the SN is attributed
to neuromelanin, which has T1-shortening properties manifest on
neuromelanin-sensitive imaging (NMS), and reduced in PD.
High
resolution susceptibility map-weighted images (SMWI) has recently been
developed to improve visualization of the nigrosome-1 region of the substantia
nigra (SN) on 3T imaging.4 SMWI utilizes susceptibility weighting
mask derived from quantitative susceptibility mapping (QSM) to enhance the
contrast for the SWI magnitude images.
In this
study, we evaluated the sensitivity of
quantitative SMWI & NMS in differentiating PD from HC.Methods
This study was approved by the local ethics board. Twenty-eight PD
patients clinically diagnosed by a movement disorder specialist and 25 healthy
controls (HC) were included in the study (Figure 1). All participants underwent
motor assessments (Figure 1), viz the Unified Parkinson’s Disease Rating Scale
(UPDRS), Hoehn and Yahr Scale (H&Y), and brain MRI
scan on a 3T scanner.
3D high resolution T2* SWI images were acquired using a multi-echo
gradient echo sequence with TR=48ms, TE=13.77/26.39/39ms, FA=20°, in-plane
resolution= 0.5x0.5x1mm3, number of slices = 32, scan duration 4:09mins. An
oblique-coronal imaging plane oriented perpendicular to the midbrain structure
was chosen (Figure 2).4
A high
resolution NMS imaging was performed using a T1 TSE sequence with TR/TE=938/15
ms, voxel size=0.5x0.5x3mm3, number of slices=13, scan duration 10:25mins.
The imaging tilting was copied from the SWI acquisition and the first slice
placement follows SWI acquisition.
QSM and SMWI images were reconstructed from the
multi-echo GRE images using SMWI software (Seoul National University, Seoul,
South Korea).4
Region-of-interest (ROI) of the SN was
manually drawn on SMWI and NMS images, whilst blinded to subject status (Figure
3). SMWI images were inspected in the superoinferior-anteroposterior direction
to identify the last slice where the inferior tail of the red nucleus was still
visible. The SN mask was drawn along its margins on the next consecutive 3
slices. A background ROI mask was placed over the decussation of the superior
cerebellar peduncles, which lies inferior to the SN.5
On the NMS
images, the SN mask was drawn on the slice corresponding to the first SMWI slice
containing the SN mask. The SN mask was drawn on this and the next inferior slice.
Histogram
analysis was performed on the mask metrics from both QSM/SMWI and NMS. The
difference in the mean susceptibility values from the SN and background masks
were computed from the QSM images. Chi-square test was used to compare the sex
distribution between PD patients and healthy controls. Mann-Whitney U test or
independent Student’s t-test was performed according to the normality of each
continuous variable distribution.Results
Clinical
demographics were reported in Figure 1. Representative images of NMS, QSM and
SMWI in a HC and PD patient were shown in Figure 4. SN masks on SWMI and NMS
were similar in volume between PD and HC (p=0.675).
Mean
quantitative values from the SN masks on QSM/SMWI and NMS images are tabulated
in Figure 5. Susceptibility values in the SN was significantly higher in PD than
HC (p<0.0001). Given that SMWI was derived from the QSM, similar results
were also found in the SN masks on SMWI, where the mean signal in the SN was
significantly lower in PD than HC.
There was no
significant difference in mean signal of the SN masks on NMS between PD and HC (p=0.104).
After filtering for voxels which are higher than background signal, the SN
masks in HC were significantly bigger than PD.Discussion
To our
knowledge, this is the first study evaluating the sensitivity of QSM/SMWI and
NMS imaging in PD. Our quantitative SMWI results confirmed and added to the existing
literature showing the utility of SMWI as a tool to visualize nigrosome-1.1,4,6
SMWI heightens the contrast between regions with high
iron content such as SN and its surrounding structures, as shown by the strong
differentiation between PD and HC in our results. As such, it would be an ideal
tool for radiologists in clinical diagnosis.
Although NMS imaging was also able to
distinguish PD and HC well, it was not as robust as SMWI in sensitivity. NMS
images needed additional post-processing to accentuate the difference between
PD and HC by filtering out signal contribution from the background which are visually
distracting. Besides, the SN boundaries on NMS images were not as crisp as those
on SMWI images, as the viable, neuromelanin-containing dopaminergic neurons appeared
more diffuse distributed on NMS images, especially in PD (Figure 4).Conclusion
Both QSM/SMWI and NMS offered
excellent differentiation of PD and HC through targeted imaging of nigrosome-1
and neuromelanin-containing
dopaminergic neurons
respectively. Nevertheless, QSM/SMWI offered more robust results compared to
NMS and may be preferred for use in the clinical setting.Acknowledgements
We would like to thank National Medical Research Council, Singapore for their funding support.References
- Kim EY, Sung
YH, Lee J. Nigrosome 1 imaging: technical considerations and clinical
applications. Br J Radiol. 2019;92(1101):20180842.
- Pavese N,
Tai YF. Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic
Evaluation of Parkinsonism. Mov Disord Clin Pract 2018;5(2):131-140.
- Schwarz ST,
Afzal M, Morgan PS, et al. The 'swallow tail' appearance of the healthy
nigrosome - a new accurate test of Parkinson's disease: a case-control and
retrospective cross-sectional MRI study at 3T. PLoS One. 2014;9(4):e93814.
- Nam Y, Gho
SM, Kim DH, et al. Imaging of nigrosome 1 in substantia nigra at 3T using
multiecho susceptibility map-weighted imaging (SMWI). J Magn Reson Imaging.
2017;46(2):528-536.
- Kim EY, Sung
YH, Shin HG, et al. Diagnosis of Early-Stage Idiopathic Parkinson’s Disease Using
High-Resolution Quantitative Susceptibility Mapping Combined with Histogram
Analysis in the Substantia Nigra at 3 T. J Clin Neurol 2018;14(1):90-97.
- Sung YH, Lee
J, Nam Y, et al. Initial diagnostic workup of parkinsonism: Dopamine
transporter positron emission tomography versus susceptibility map-weighted
imaging at 3T. Parkinsonism Relat Disord. 2019 May;62:171-178.